REGN (Regeneron Pharmac)
All Pro Portfolios with REGN
- Total Pro Portfolios with REGN:
- Carl Icahn
- show more
All Do-It-Yourself Portfolios with REGN
- Total Do-It-Yourself Portfolios with REGN:
- keith Portfolio 2
- john n Portfolio 1
- Kevin Furlong Portfolio 1
- Profile 1
- topler Portfolio 1
- JMStocker Portfolio 1
- hhennebry Portfolio 1
- cjustus Portfolio 1
- jazzist Portfolio 1
- durbin5x5 Portfolio 1
- nancylou45 Portfolio 1
- PART 7 JPMorgan 26th Annual Healthcare Conf 1/10/08..4th Day Reporting Companies..Nymph Take
- Barron's R&D Stock Picks
- ASCO 2009 Nymph's Watch List.
- show more
- 28
- David Miller Portfolio 1
- marty furlong Portfolio 1
- John C. Portfolio 1
- Chet 3
- kwylie Portfolio 1
- SUPRATRADE-QUANTUM MEGA 7
- SUPRATRADE 1104070303 Failing Down
- rlacreta Portfolio 1
- Mine, all mine
- BlitzFund - Healthcare
- Icar
- ASCO is coming...Papers released May 15
- Barron's Research Reports 4-04-2009
- Top Biotech Short Squeeze Plays for July
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
Date:07 05 09 |
|
10.5 |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:09 27 08 |
Pfizer (PFE) and Schering-Plough (SGP) continue to invest in R&D, but have battered shares, so they outrank Wyeth (WYE). Regeneron Pharmaceutical (REGN) rates higher than more richly valued biotechs like Amgen (AMGN) or Vertex Pharmaceuticals (VRTX). The idea here is inspired by the value-investing tradition: Buy a dollar of research for fifty cents. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
They Just Don't Get Biotech! |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |
